The spinal med device market appears to be stabilizing with growth in 3 key areas, according to a letter to investors published this week from Leerink Partner’s Richard Newitter, who attended the North American Spine Society’s annual meeting in Chicago last week. Newitter said the meeting was “neutral-to-positive” for firms in the spinal market, and said […]
K2M
K2M tops estimates with prelims, plans $101m offering
K2M (NSDQ:KTWO) this week released preliminary Q2 results and priced a $101 million follow-on offering for its line of spinal implants. Leesburg, Va.-based K2M said it expects to post losses of -$8.5 million to -$6.5 million on sales of $55.9 million to $56.4 million for the 3 months ended June 30, paring its losses from -$17.7 million on sales […]
K2M Group prices $38m follow-on
VCs put more into medtech last year | Medtech funding for the week of January 19, 2015
K2M registers for $40m follow-on
2014: The year of the medtech IPO | Medtech Wall Street news for the week of December 15, 2014
Year in review: 2014 was the year of the medtech IPO
Abbott to expand medical device footprint? | Medtech Wall Street news for the week of May 12, 2014
Spinal firm K2M’s $120M IPO hits the mark | MassDevice.com On Call
MASSDEVICE ON CALL — K2M Group’s (NSDQ:KTWO) initial public offering landed right on target with $120 million in net proceeds, even though the company lowered its per-share price.
K2M prices IPO under range at $132M
K2M Group cut the price on its initial public offering to $15 per share, with trading in the stock slated to begin today on the NASDAQ exchange under the KTWO symbol.
K2M’s IPO could reap as much as $183M
K2M Group Holdings, the largest privately held spinal implant maker, said today that its forthcoming initial public offering could be worth up to $183 million.
K2M announced its plans for a U.S. IPO early this year, saying in March that the launch could be worth $100 million.